why choose us

Clinical Trials Search

Showing 4,430 of 132,085 result(s)
The Balance Recovery Confidence (Brc) Scale

Status: COMPLETED

Condition: Old Age

Interventions:

Date: 2024-05-30

Clinical Variables and Dyspnea and Fear of Movement in Chronic Obstructive Pulmonary Patients

Status: COMPLETED

Condition: COPD

Interventions: Kinesiophobia Level Due to Dyspnea

Date: 2024-05-29

Pharmacokinetics of Bisoprolol and SGLT2i in Acutely Decompensated Heart Failure

Status: COMPLETED

Condition: Acute Decompensated Heart Failure

Interventions: DRUG: Recompensation (guideline directed medical therapy) - Recompensation mainly achieved by intravenous diuretics and/or vasodilators but no require

Date: 2024-05-29

Clinical Trial to Investigate the Effects of Food on the Pharmacokinetics and Safety of Orally Administered Radotinib

Status: COMPLETED

Condition: Drug Kinetics

Interventions:

  1. Brand name;manufacturer: Supect Cap.;IL-YANG PHARM.
    Co., Ltd.
  2. Active ingredient: radotinib HCl 106.8mg (100mg as radoti

    Date: 2024-05-29

First Human Trial of Targeting MDM2;MDMX PET Imaging

Status: COMPLETED

Condition: MDM2;MDMX Gene Mutation

Interventions:

Utilizing a peptide with high affinity to MDM2;MDMX as the targeting moiety for radiopharmaceuticals, this study explores the diagnostic effic

Date: 2024-05-29

A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight

Status: COMPLETED

Condition: Healthy

Interventions: Administered orally

Date: 2024-05-29

A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight

Status: COMPLETED

Condition: Healthy

Interventions: Administered orally

Date: 2024-05-29

Next Generation Rocklatan

Status: COMPLETED

Condition: Open Angle Glaucoma

Interventions: Investigational monotherapy supplied in three concentration levels: low, medium, high

Date: 2024-05-29

Phase I PK Study of Budesonide;Albuterol Delivered From PT027 in Healthy Chinese Participants.

Status: COMPLETED

Condition: Healthy Volunteer

Interventions: BDA MDI 160 ?g;180 ?g (single dose administered as 2 actuations of 80 ?g;90 ?g)

Date: 2024-05-29